News Releases

2010

XXX
Dec.10,2010
Results of Phase Ⅱb Study of Carfizomib were Presented at the 52nd American Society of Hematology Annual Meeting (69.0KB)
XXX
Nov.11,2010
Approval Received for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder (16.9KB)
XXX
Nov.04,2010
Announcement on Acquisition of the Company's Own Shares (58.6KB)
XXX
Oct.28,2010
Ono and MSD Submit Additional Indication Application for Sitagliptin Combination Therapy with Insulin (90.9KB)
XXX
Sep.24,2010
Application Filed in Japan for an Intravenous Antiemetic Selective Neurokinin-1 (NK1) Receptor Antagonist (17.1KB)
XXX
Sep.10,2010
Application for RECALBON® Tablets 50mg/ Bonoteo® Tablets 50mg,A Monthly Oral Osteoporosis Treatment in Japan (15.5KB)
XXX
Sep.08,2010
Ono Announces Carfilzomib Development and Commercialization Agreement with Onyx Pharmaceuticals for Japan (81.5KB)
XXX
Sep.08,2010
Revisions of Consolidated Financial Forecasts (52.8KB)
XXX
Sep.01,2010
Ono Enters into License Agreement with Concordia for New Therapeutic Agent for Pancreatic Cancer (16.1KB)
XXX
Jul.29,2010
NDA Submission in Japan for Onoact® 50 for Injection, Short-Acting Selective β1 Blocker for Improvement of Image Quality of Coronary Arteries for Coronary CT Angiography (45.1KB)
XXX
Jun.24,2010
Ono and Banyu File Additional Indication Application for Type-2 Diabetes Drug Sitagliptin - Combination Therapy with α-Glucosidase Inhibitors - (344KB)
XXX
Mar.23,2010
Ono Enters into Drug Discovery Agreement on Bioactive Lipid with BioSeek (20.2KB)
XXX
Mar.01,2010
NDA Submission in Japan for rivastigmine patch,the first transdermal patch therapy to treat Alzheimer's disease (11.4KB)
XXX
Feb.04,2010
Ono to Support Relief Efforts for Haitian Earthquake Victims (9.7KB)
XXX
Jan.07,2010
Application filed for Orally Disintegrating Tablet of imidafenacin (INN),a Drug for Overactive Bladder (11.9KB)